Page 12 of 66:  1  [  11  12  13  14  15  16  17  18  19  20 ]  21   31   41   51   61 

#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1101	33	48	4737 2003 CANCER LETTERS 194 (2): 189-197 Karlseder J Telomere repeat binding factors: keeping the ends in check	30	37
1102	67	103	4738 2003 CANCER LETTERS 194 (2): 209-219 Saretzki G Telomerase inhibition as cancer therapy	15	31
1103	14	27	5234 2004 CANCER LETTERS 203 (1): 79-86 Rebuzzini P; Lisa A; Giulotto E; Mondello C Chromosomal end-to-end fusions in immortalized mouse embryonic fibroblasts deficient in the DNA-dependent protein kinase catalytic subunit	0	2
1104	12	25	5235 2004 CANCER LETTERS 212 (1): 15-20 Eitsuka T; Nakagawa K; Igarashi M; Miyazawa T Telomerase inhibition by sulfoquinovosyldiacylglycerol from edible purple laver (Porphyra yezoensis)	2	6
1105	53	81	5236 2004 CANCER LETTERS 212 (2): 135-144 Londono-Vallejo JA Telomere length heterogeneity and chromosome instability	2	8
1106	24	37	5775 2005 CANCER LETTERS 218 (2): 207-213 Yeh YM; Pan YT; Wang TCV Cdc42/Rac1 participates in the control of telomerase activity in human nasopharyngeal cancer cells	0	0
1107	22	36	5776 2005 CANCER LETTERS 222 (1): 83-88 Dettlaff-Pokora A; Matuszewski M; Schlichtholz B Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer	0	2
1108	15	25	5777 2005 CANCER LETTERS 227 (2): 169-174 Huang PR; Yeh YM; Wang TCV Potent inhibition of human telomerase by helenalin	0	1
1109	6	36	6292 2006 CANCER LETTERS 232 (2): 189-198 Mei YP; Zhu XF; Zhou JM; Huang H; Deng R; et al. siRNA targeting LMP1-induced apoptosis in EBV-positive lymphoma cells is associated with inhibition of telornerase activity and expression	0	0
1110	14	18	1422 1994 CANCER RESEARCH 54 (1): 236-241 MEHLE C; LJUNGBERG B; ROOS G TELOMERE SHORTENING IN RENAL-CELL CARCINOMA	65	87
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1111	9	34	1423 1994 CANCER RESEARCH 54 (13): 3557-3560 OHYASHIKI JH; OHYASHIKI K; FUJIMURA T; KAWAKUBO K; SHIMAMOTO T; et al. TELOMERE SHORTENING ASSOCIATED WITH DISEASE EVOLUTION PATTERNS IN MYELODYSPLASTIC SYNDROMES	45	82
1112	10	20	1617 1995 CANCER RESEARCH 55 (12): 2533-2536 CHADENEAU C; HAY K; HIRTE HW; GALLINGER S; BACCHETTI S TELOMERASE ACTIVITY ASSOCIATED WITH ACQUISITION OF MALIGNANCY IN HUMAN COLORECTAL-CANCER	224	325
1113	14	20	1618 1995 CANCER RESEARCH 55 (15): 3258-3262 HIYAMA E; YOKOYAMA T; TATSUMOTO N; HIYAMA K; IMAMURA Y; et al. TELOMERASE ACTIVITY IN GASTRIC-CANCER	260	395
1114	17	29	1619 1995 CANCER RESEARCH 55 (20): 4566-4569 BEDNAREK A; BUDUNOVA I; SLAGA TJ; ALDAZ CM INCREASED TELOMERASE ACTIVITY IN MOUSE SKIN PREMALIGNANT PROGRESSION	36	57
1115	26	41	1858 1996 CANCER RESEARCH 56 (1): 218-222 Sommerfeld HJ; Meeker AK; Piatyszek MA; Bova GS; Shay JW; et al. Telomerase activity: A prevalent marker of malignant human prostate tissue	153	279
1116	22	34	1859 1996 CANCER RESEARCH 56 (3): 645-650 Avilion AA; Piatyszek MA; Gupta J; Shay JW; Bacchetti S; et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues	175	274
1117	12	22	1860 1996 CANCER RESEARCH 56 (7): 1503-1508 Albanell J; Han W; Mellado B; Gunawardane R; Scher HI; et al. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines	65	112
1118	8	24	1861 1996 CANCER RESEARCH 56 (15): 3530-3533 Mutirangura A; Supiyaphun P; Trirekapan S; Sriuranpong V; Sakuntabhai A; et al. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma	44	72
1119	18	34	1862 1996 CANCER RESEARCH 56 (16): 3796-3802 Bestilny LJ; Brown CB; Miura Y; Robertson LD; Riabowol KT Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines	65	117
1120	13	23	1863 1996 CANCER RESEARCH 56 (24): 5600-5604 Mao L; ElNaggar AK; Fan YH; Lee JS; Lippman SM; et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues	38	90
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1121	7	12	1864 1996 CANCER RESEARCH 56 (24): 5720-5722 Califano J; Ahrendt SA; Meininger G; Westra WH; Koch WM; et al. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients	40	80
1122	20	42	2167 1997 CANCER RESEARCH 57 (2): 326-331 Hiyama E; Kodama T; Shinbara K; Iwao T; Itoh M; et al. Telomerase activity is detected in pancreatic cancer but not in benign tumors	52	125
1123	12	26	2168 1997 CANCER RESEARCH 57 (3): 370-374 Ueda M; Ouhtit A; Bito T; Nakazawa K; Lubbe J; et al. Evidence for UV-associated activation of telomerase in human skin	38	70
1124	27	54	2169 1997 CANCER RESEARCH 57 (3): 549-554 Landberg G; Nielsen NH; Nilsson P; Emdin SO; Cajander J; et al. Telomerase activity is associated with cell cycle deregulation in human breast cancer	34	67
1125	21	27	2170 1997 CANCER RESEARCH 57 (4): 610-614 Kyo S; Takakura M; Kohama T; Inoue M Telomerase activity in human endometrium	105	164
1126	18	24	2171 1997 CANCER RESEARCH 57 (10): 1863-1867 Kyo S; Takakura M; Ishikawa H; Sasagawa T; Satake S; et al. Application of telomerase assay for the screening of cervical lesions	28	54
1127	19	32	2172 1997 CANCER RESEARCH 57 (11): 2100-2103 Ohyashiki K; Ohyashiki JH; Nishimaki J; Toyama K; Ebihara Y; et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay	34	65
1128	11	28	2173 1997 CANCER RESEARCH 57 (11): 2144-2147 Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; et al. Telomerase activity: A marker to distinguish follicular thyroid adenoma from carcinoma	30	77
1129	29	37	2174 1997 CANCER RESEARCH 57 (13): 2760-2764 Brien TP; Kallakury BVS; Lowry CV; Ambros RA; Muraca PJ; et al. Telomerase activity in benign endometrium and endometrial carcinoma	32	53
1130	21	24	2532 1998 CANCER RESEARCH 58 (7): 1558-1561 Takakura M; Kyo S; Kanaya T; Tanaka M; Inoue M Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer	82	184
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1131	21	29	2533 1998 CANCER RESEARCH 58 (9): 1909-1913 Pai RB; Pai SB; Kukhanova M; Dutschman GE; Guo X; et al. Telomerase from human leukemia cells: Properties and its interaction with deoxynucleoside analogues	27	31
1132	39	64	2534 1998 CANCER RESEARCH 58 (10): 2117-2125 Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; et al. Telomerase activity and alterations in telomere length in human brain tumors	32	59
1133	12	19	2535 1998 CANCER RESEARCH 58 (18): 4052-4054 Tang RP; Cheng AJ; Wang JY; Wang TCV Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis	29	46
1134	31	36	2536 1998 CANCER RESEARCH 58 (18): 4168-4172 Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts	120	223
1135	31	41	2537 1998 CANCER RESEARCH 58 (21): 4918-4922 Bechter OE; Eisterer W; Pall G; Hilbe W; Kuhr T; et al. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia	32	52
1136	26	35	2538 1998 CANCER RESEARCH 58 (23): 5406-5410 Yokoyama Y; Takahashi Y; Shinohara A; Lian ZL; Wan XY; et al. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells	56	76
1137	25	34	2962 1999 CANCER RESEARCH 59 (3): 551-557 Takakura M; Kyo S; Kanaya T; Hirano H; Takeda J; et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells	116	249
1138	22	29	2963 1999 CANCER RESEARCH 59 (3): 639-644 Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; et al. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells	68	113
1139	15	32	2964 1999 CANCER RESEARCH 59 (4): 826-830 Horikawa I; Cable PL; Afshari C; Barrett JJ Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene	79	173
1140	18	31	2965 1999 CANCER RESEARCH 59 (16): 4004-4011 Naasani I; Seimiya H; Yamori T; Tsuruo T FJ5002: A potent telomerase inhibitor identified by exploiting the disease-oriented screening program with COMPARE analysis	38	56
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1141	38	52	2966 1999 CANCER RESEARCH 59 (17): 4301-4307 Dome JS; Chung S; Bergemann T; Umbricht CB; Saji M; et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor	21	58
1142	18	35	2967 1999 CANCER RESEARCH 59 (23): 5917-5921 Kyo S; Takakura M; Kanaya T; Zhuo W; Fujimoto K; et al. Estrogen activates telomerase	70	146
1143	19	37	2968 1999 CANCER RESEARCH 59 (24): 6118-6123 Sun W; Kang KS; Morita I; Trosko JE; Chang CC High susceptibility of a human breast epithelial cell type with stem cell characteristics to telomerase activation and immortalization	2	26
1144	33	51	3374 2000 CANCER RESEARCH 60 (3): 610-617 Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MAS Telomerase activity and telomere length in acute and chronic leukemia, pre-and post-ex vivo culture	27	62
1145	7	29	3375 2000 CANCER RESEARCH 60 (9): 2372-2376 Hisama FM; Chen YH; Meyn MS; Oshima J; Weissman SM WRN or telomerase constructs reverse 4-nitroquinoline 1-oxide sensitivity in transformed Werner syndrome fibroblasts	9	27
1146	10	22	3376 2000 CANCER RESEARCH 60 (11): 2770-2774 Figueroa R; Lindenmaier H; Hergenhahn M; Nielsen KV; Boukamp P Telomere erosion varies during in vitro aging of normal human fibroblasts from young and adult donors	9	20
1147	28	57	3794 2001 CANCER RESEARCH 61 (7): 3053-3061 Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; et al. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase	50	73
1148	29	49	3795 2001 CANCER RESEARCH 61 (14): 5529-5536 Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; et al. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells	6	20
1149	32	42	3796 2001 CANCER RESEARCH 61 (14): 5580-5586 Sachsinger J; Gonzalez-Suarez E; Samper E; Heicappell R; Muller M; et al. Telomerase inhibition in RenCa, a murine tumor cell line with short telomeres, by overexpression of a dominant negative mTERT mutant, reveals fundamental differences in telomerase regulation between human and murine cells	8	14
1150	34	72	3797 2001 CANCER RESEARCH 61 (20): 7594-7602 Ducrest AL; Amacker M; Mathieu YD; Cuthbert AP; Trott DA; et al. Regulation of human telomerase activity: Repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity	23	39
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1151	14	50	4240 2002 CANCER RESEARCH 62 (2): 552-559 Franco S; Segura I; Riese HH; Blasco MA Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres	20	25
1152	32	54	4241 2002 CANCER RESEARCH 62 (7): 2104-2114 Boklan J; Nanjangud G; MacKenzie KL; May C; Sadelain M; et al. Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts	10	20
1153	10	34	4242 2002 CANCER RESEARCH 62 (9): 2600-2605 Schroers R; Huang XF; Hammer J; Zhang JW; Chen SY Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+T-helper cells	3	28
1154	14	46	4243 2002 CANCER RESEARCH 62 (11): 3184-3194 Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; et al. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit	1	32
1155	35	46	4244 2002 CANCER RESEARCH 62 (11): 3226-3232 Huang JJ; Lin MC; Bai YX; Jing DD; Wong BCY; et al. Ectopic expression of a COOH-terminal fragment of the human telomerase reverse transcriptase leads to telomere dysfunction and reduction of growth and tumorigenicity in HeLa cells	1	4
1156	25	29	4245 2002 CANCER RESEARCH 62 (12): 3365-3368 Gomez D; Mergny JL; Riou JF Detection of telomerase inhibitors based on G-quadruplex ligands by a modified telomeric repeat amplification protocol assay	9	17
1157	8	43	4246 2002 CANCER RESEARCH 62 (13): 3876-3882 Akiyama M; Hideshima T; Hayashi T; Tai YT; Mitsiades CS; et al. Cytokines modulate telomerase activity in a human multiple myeloma cell line	21	53
1158	5	31	4247 2002 CANCER RESEARCH 62 (17): 5041-5048 Su Z; Vieweg J; Weizer AZ; Dahm P; Yancey D; et al. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product	2	46
1159	23	56	4248 2002 CANCER RESEARCH 62 (22): 6405-6409 Meeker AK; Hicks JL; Platz EA; March GE; Bennett CJ; et al. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis	21	36
1160	12	58	4739 2003 CANCER RESEARCH 63 (2): 476-483 Piboonniyom SO; Duensing S; Swilling NW; Hasskarl J; Hinds PW; et al. Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability	1	14
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1161	18	37	4740 2003 CANCER RESEARCH 63 (3): 579-585 Mo YQ; Gan YB; Song SH; Johnston J; Xiao XD; et al. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach	17	22
1162	16	43	4741 2003 CANCER RESEARCH 63 (4): 824-830 Naasani I; Oh-hashi F; Oh-hara T; Feng WY; Johnston J; et al. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo	11	41
1163	15	20	4742 2003 CANCER RESEARCH 63 (8): 1759-1763 Ulaner GA; Huang HY; Otero J; Zhao ZQ; Ben-Porat L; et al. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma	20	38
1164	15	50	4743 2003 CANCER RESEARCH 63 (8): 1914-1919 Herbert BS; Pearce VP; Hynan LS; LaRue DM; Wright WE; et al. A peroxisome proliferator-activated receptor-gamma agonist and the p53 rescue drug CP-31398 inhibit the spontaneous immortalization of breast epithelial cells	0	6
1165	18	49	4744 2003 CANCER RESEARCH 63 (10): 2589-2595 Wu GK; Jiang XZ; Lee WH; Chen PL Assembly of functional ALT-associated promyelocytic leukemia bodies requires Nijmegen breakage syndrome 1	13	29
1166	29	49	4745 2003 CANCER RESEARCH 63 (12): 3247-3256 Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures	18	35
1167	8	20	4746 2003 CANCER RESEARCH 63 (13): 3490-3494 Folini M; Berg K; Millo E; Villa R; Prasmickaite L; et al. Photochemical internalization of a peptide nucleic acid targeting the catalytic subunit of human telomerase	8	23
1168	13	27	4747 2003 CANCER RESEARCH 63 (13): 3750-3754 Falchetti ML; Pierconti F; Casalbore P; Maggiano N; Levi A; et al. Glioblastoma induces vascular endothelial cells to express telomerase in vitro	5	15
1169	21	50	4748 2003 CANCER RESEARCH 63 (18): 5813-5820 Velicescu M; Yu JM; Herbert BS; Shay JW; Granada E; et al. Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells	0	2
1170	27	50	4749 2003 CANCER RESEARCH 63 (18): 5917-5925 Chen Z; Koeneman KS; Corey DR Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells	17	24
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1171	18	22	4750 2003 CANCER RESEARCH 63 (19): 6149-6153 Gomez D; Aouali N; Renaud A; Douarre C; Shin-ya K; et al. Resistance to senescence induction and telomere shortening by a G-quadruplex ligand inhibitor of telomerase	11	13
1172	12	31	4751 2003 CANCER RESEARCH 63 (19): 6187-6194 Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; et al. Effects of oligonucleotide N3 '-> P5 ' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells	8	15
1173	15	23	4752 2003 CANCER RESEARCH 63 (21): 7047-7050 Gonzalez-Suarez E; Goytisolo FA; Flores JM; Blasco MA Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-Methyl-N-Nitrosourea	5	7
1174	29	79	4753 2003 CANCER RESEARCH 63 (21): 7147-7157 Milyavsky M; Shats I; Erez N; Tang XH; Senderovich S; et al. Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype	10	30
1175	31	53	4754 2003 CANCER RESEARCH 63 (22): 7679-7688 Patry C; Bouchard L; Labrecque P; Gendron D; Lemieux B; et al. Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines	3	18
1176	10	73	4755 2003 CANCER RESEARCH 63 (22): 7936-7941 Lanson NA; Friedlander PL; Schwarzenberger P; Kolls JK; Wang GS Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis	4	16
1177	26	74	4756 2003 CANCER RESEARCH 63 (23): 8188-8196 Qi L; Strong MA; Karim BO; Armanios M; Huso DL; et al. Short telomeres and ataxia-telangiectasia mutated deficiency cooperatively increase telomere dysfunction and suppress tumorigenesis	11	16
1178	10	33	5237 2004 CANCER RESEARCH 64 (2): 463-467 Yang H; On CC; Feldman RI; Nicosia SV; Kruk PA; et al. Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells	1	12
1179	34	53	5238 2004 CANCER RESEARCH 64 (2): 523-529 Kondo T; Oue N; Yoshida K; Mitani Y; Naka K; et al. Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma	5	21
1180	33	55	5239 2004 CANCER RESEARCH 64 (2): 639-643 Grimm J; Perez JM; Josephson L; Weissleder R Novel nanosensors for rapid analysis of telomerase activity	1	16
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1181	5	35	5240 2004 CANCER RESEARCH 64 (6): 2153-2161 Verra NCV; Jorritsma A; Weijer K; Ruizendaal JJ; Voordouw A; et al. Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice	5	15
1182	23	31	5241 2004 CANCER RESEARCH 64 (10): 3444-3451 Bechter OE; Zou Y; Walker W; Wright WE; Shay JW Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition	28	36
1183	28	63	5242 2004 CANCER RESEARCH 64 (11): 3830-3837 Fotiadou P; Henegariu O; Sweasy JB DNA polymerase beta interacts with TRF2 and induces telomere dysfunction in a murine mammary cell line	2	6
1184	32	43	5243 2004 CANCER RESEARCH 64 (14): 4833-4840 Li S; Rosenberg JE; Donjacour AA; Botchkina IL; Hom YK; et al. Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA	35	35
1185	17	48	5244 2004 CANCER RESEARCH 64 (17): 6144-6151 Sun BC; Huang Q; Liu SX; Chen MZ; Hawks CL; et al. Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocortical cells and restoration of tumorigenicity by human telomerase reverse transcriptase	1	7
1186	26	39	5245 2004 CANCER RESEARCH 64 (20): 7271-7278 Jaco I; Munoz P; Blasco MA Role of human Ku86 in telomere length maintenance and telomere capping	7	10
1187	27	44	5778 2005 CANCER RESEARCH 65 (4): 1489-1496 Burger AM; Dai FP; Schultes CM; Reszka AP; Moore MJ; et al. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function	14	22
1188	7	59	5779 2005 CANCER RESEARCH 65 (6): 2179-2185 Gil J; Kerai P; Lleonart M; Bernard D; Cigudosa JC; et al. Immortalization of primary human prostate epithelial cells by c-Myc	0	6
1189	10	34	5780 2005 CANCER RESEARCH 65 (6): 2321-2329 Dalerba P; Guiducci C; Poliani PL; Cifola I; Parenza M; et al. Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: Evidence against immortality as a constitutive trait of tumor cells	1	3
1190	34	50	5781 2005 CANCER RESEARCH 65 (7): 2722-2729 Fasching CL; Bower K; Reddel RR Merase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies	7	8
#	LCR	NCR	Node / Date / Journal / Author	LCS	GCS
1191	23	41	5782 2005 CANCER RESEARCH 65 (7): 2730-2737 Marciniak RA; Cavazos D; Montellano R; Chen QJ; Guarente L; et al. A novel telomere structure in a human alternative lengthening of telomeres cell line	7	8
1192	11	57	5783 2005 CANCER RESEARCH 65 (12): 5344-5351 McHugh MM; Gawron LS; Matsui SI; Beerman TA The antitumor enediyne C-1027 alters cell cycle progression and induces chromosomal aberrations and telomere dysfunction	1	4
1193	3	21	5784 2005 CANCER RESEARCH 65 (15): 6516-6520 Konnikova L; Simeone MC; Kruger MM; Kotecki M; Cochran BH Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells	1	2
1194	26	46	5785 2005 CANCER RESEARCH 65 (17): 7866-7873 Dikmen ZG; Gellert GC; Jackson S; Gryaznov S; Tressler R; et al. In vivo inhibition of lung cancer by GRN163L: A novel human telomerase inhibitor	4	5
1195	19	52	6293 2006 CANCER RESEARCH 66 (4): 2107-2115 Jagadeesh S; Kyo S; Banerjee PP Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells	0	0
1196	37	56	6294 2006 CANCER RESEARCH 66 (7): 3584-3592 Brachner A; Sasgary S; Pirker C; Rodgarkia C; Mikula M; et al. Telomerase-and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: Effect of ectopic hTERT	0	0
1197	29	37	6295 2006 CANCER RESEARCH 66 (11): 5763-5771 Goldkorn A; Blackburn EH Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle arrest in human cancer cells	0	0
1198	3	26	1096 1992 CANCER RESEARCH THERAPY & CONTROL 3 (1): 69-74 BUCOVAZ ET B-PROTEINS HYPOTHETICAL RELATIONSHIP TO THE PERPETUATION OF THE CARCINOGENIC PROCESS AND OTHER PROCESSES	0	1
1199	10	39	5786 2005 CANCER SCIENCE 96 (9): 607-613 Painter RG; Lanson NA; Jin ZM; Park F; Wang GS Conditional expression of a suicide gene by the telomere reverse transcriptase promoter for potential post-therapeutic deletion of tumorigenesis	1	3
1200	83	120	1865 1996 CANCER SURVEYS 28: 197-216 Bacchetti S Telomere maintenance in tumour cells	17	30

Page 12 of 66:  1  [  11  12  13  14  15  16  17  18  19  20 ]  21   31   41   51   61 
Generated by HistCite 2006.08.14